Structural and functional characterization of the Sin Nombre virus L protein.
Journal
PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
10
02
2023
accepted:
04
07
2023
medline:
9
8
2023
pubmed:
7
8
2023
entrez:
7
8
2023
Statut:
epublish
Résumé
The Bunyavirales order is a large and diverse group of segmented negative-strand RNA viruses. Several virus families within this order contain important human pathogens, including Sin Nombre virus (SNV) of the Hantaviridae. Despite the high epidemic potential of bunyaviruses, specific medical countermeasures such as vaccines or antivirals are missing. The multifunctional ~250 kDa L protein of hantaviruses, amongst other functional domains, harbors the RNA-dependent RNA polymerase (RdRp) and an endonuclease and catalyzes transcription as well as replication of the viral RNA genome, making it a promising therapeutic target. The development of inhibitors targeting these key processes requires a profound understanding of the catalytic mechanisms. Here, we established expression and purification protocols of the full-length SNV L protein bearing the endonuclease mutation K124A. We applied different biochemical in vitro assays to provide an extensive characterization of the different enzymatic functions as well as the capacity of the hantavirus L protein to interact with the viral RNA. By using single-particle cryo-EM, we obtained a 3D model including the L protein core region containing the RdRp, in complex with the 5' promoter RNA. This first high-resolution model of a New World hantavirus L protein shows striking similarity to related bunyavirus L proteins. The interaction of the L protein with the 5' RNA observed in the structural model confirms our hypothesis of protein-RNA binding based on our biochemical data. Taken together, this study provides an excellent basis for future structural and functional studies on the hantavirus L protein and for the development of antiviral compounds.
Identifiants
pubmed: 37549153
doi: 10.1371/journal.ppat.1011533
pii: PPATHOGENS-D-23-00259
pmc: PMC10406178
doi:
Substances chimiques
RNA-Dependent RNA Polymerase
EC 2.7.7.48
RNA, Viral
0
Endonucleases
EC 3.1.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1011533Informations de copyright
Copyright: © 2023 Meier et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Nat Commun. 2021 Dec 2;12(1):7018
pubmed: 34857749
PLoS Pathog. 2023 Jan 12;19(1):e1011060
pubmed: 36634042
Nat Commun. 2022 Feb 16;13(1):902
pubmed: 35173159
PLoS Pathog. 2017 May 15;13(5):e1006400
pubmed: 28505175
Nat Methods. 2013 Jun;10(6):584-90
pubmed: 23644547
Nature. 2020 Mar;579(7800):615-619
pubmed: 32214249
Vector Borne Zoonotic Dis. 2010 Aug;10(6):563-74
pubmed: 19874190
J Biol Chem. 1999 Jan 29;274(5):2706-16
pubmed: 9915801
J Virol. 2022 Feb 9;96(3):e0171321
pubmed: 34787453
Nat Commun. 2020 Jul 17;11(1):3590
pubmed: 32681014
Nucleic Acids Res. 2017 Apr 7;45(6):3353-3368
pubmed: 28126917
Trends Microbiol. 2020 Apr;28(4):293-303
pubmed: 31948728
J Virol. 1995 Sep;69(9):5754-62
pubmed: 7637020
Cell. 2020 May 14;181(4):877-893.e21
pubmed: 32304664
J Biol Chem. 2019 May 17;294(20):8088-8100
pubmed: 30926610
Nat Methods. 2017 Mar;14(3):290-296
pubmed: 28165473
J Virol. 2013 Jun;87(12):6975-85
pubmed: 23576516
Cell. 2015 Jun 4;161(6):1267-79
pubmed: 26004069
Nature. 2014 Dec 18;516(7531):355-60
pubmed: 25409142
Front Microbiol. 2015 Nov 27;6:1326
pubmed: 26640463
Nat Methods. 2006 Dec;3(12):1021-32
pubmed: 17117155
Virus Res. 2017 Apr 15;234:118-134
pubmed: 28137457
Crit Rev Microbiol. 2018 Sep;44(5):522-540
pubmed: 29516765
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):4972-7
pubmed: 11309487
PLoS Pathog. 2016 Jun 14;12(6):e1005635
pubmed: 27300328
Nature. 2014 Dec 18;516(7531):361-6
pubmed: 25409151
Emerg Infect Dis. 2020 Dec;26(12):3020-3024
pubmed: 33219792
PLoS Pathog. 2019 May 28;15(5):e1007829
pubmed: 31136637
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Nucleic Acids Res. 2023 Feb 22;51(3):1424-1442
pubmed: 36651274
Nat Rev Microbiol. 2016 Aug;14(8):479-93
pubmed: 27396566
Trends Biochem Sci. 2012 Feb;37(2):49-57
pubmed: 22154230
Proc Natl Acad Sci U S A. 2019 May 21;116(21):10518-10524
pubmed: 31072925
Structure. 2021 Oct 7;29(10):1192-1199.e4
pubmed: 34048698
PLoS Pathog. 2016 Jun 15;12(6):e1005636
pubmed: 27304209
Virology. 2001 Sep 1;287(2):251-60
pubmed: 11531403
Protein Sci. 2018 Jan;27(1):135-145
pubmed: 28884485
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21
pubmed: 20124702
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W471-4
pubmed: 23620284
Arch Virol. 2019 Mar;164(3):927-941
pubmed: 30663021
Biochem J. 2021 Dec 22;478(24):4169-4185
pubmed: 34783343
Nucleic Acids Res. 2020 Jun 4;48(10):5749-5765
pubmed: 32313945
Emerg Infect Dis. 2017 May;23(5):733-739
pubmed: 28418312
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20069-74
pubmed: 20978208
Curr Top Microbiol Immunol. 2001;256:15-32
pubmed: 11217402
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W320-4
pubmed: 24753421
J Struct Biol. 2012 Dec;180(3):519-30
pubmed: 23000701